Literature DB >> 2514401

Enhancement of cytokine production and natural killer activity by an Escherichia coli extract.

J Wybran1, M Libin, L Schandene.   

Abstract

OM-89 is a bacterial extract of E. coli which is clinically used in the treatment of urinary tract infections. Since immunological mechanisms may play a role in its action, its immunological effects were evaluated in vitro on peripheral blood mononuclear cells. The results showed that OM-89 enhances natural killer activity, as well as the spontaneous production of alpha-TNF and IL2. In the presence of various mitogens, it enhanced the production of IL1, gamma-IF, alpha-TNF and IL2. These data indicate that OM-89 acts on cell-mediated mechanisms by a direct and/or an indirect effect on monocytes, T cells and natural killer cells. These data suggest that the clinical activity by OM-89 may be related to its immunological properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514401     DOI: 10.1159/000216699

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  7 in total

1.  Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

Authors:  T L Vischer
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators.

Authors:  W G Bessler; B Kleine; C Martinez Alonso; L Biesert; M Strecker; K H Wiesmüller; J Metzger; G Jung
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis.

Authors:  Seung-Ju Lee; Sae Woong Kim; Yong-Hyun Cho; Moon Soo Yoon
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

Review 4.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

5.  Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.

Authors:  J P Hauzeur; T Appelboom
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  In vitro Superoxide Production by Peripheral Neutrophils from Patients with Inflammatory Bowel Disease.

Authors:  O H Nielsen; D Berild; I Ahnfelt-Rønne
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

7.  Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response.

Authors:  S Baladi; S Kantengwa; Y R Donati; B S Polla
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.